What's new

Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 13, Status: Authorised

Mar 6, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Fit for every application: MAN electric and conventional at Bauma 2025

Next Article

European Energy secures financing for 148MW solar project in Latvia

Related Posts

Applications for new human medicines under evaluation: ...

Feb 10, 2025  0

Agenda of the COMP meeting 3-5 December 2024

Feb 21, 2025  0

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:00 (CEST) to 9 May 2025, 16:45 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 9, 2025  0